Market Size of Occlusion Devices Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 7.50 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | High |
Major Players*Disclaimer: Major Players sorted in no particular order |
Occlusion Devices Market Analysis
The occlusion devices market is expected to register a CAGR of 7.5% during the forecast period.
The COVID-19 pandemic had ramifications on various surgical procedures. Due to the lockdown restrictions, a delay in diagnosis and treatments was observed in patients with various lifestyle-related and chronic diseases as a result of a reduction in hospital visits, which impacted the market studied. For instance, according to the research study published in August 2020, the COVID-19 pandemic negatively impacted interventional radiology services in Canada, especially for elective cases. As per the study, about 49.3% of the respondents reported that there was an overall decline in interventional radiology services in the country. Thus, this data indicates that surgical procedures declined due to the pandemic scenario, which, in turn, affected the occlusion devices market. However, due to the vaccinations and declining cases of COVID-19, the market studied has bounced back to its full potential.
The major factors for the growth of the market include the higher acceptance rate of minimally invasive surgeries (MIS) over traditional surgeries, the increasing prevalence of lifestyle-related and chronic diseases, and technological advancements in the area. For instance, according to the WHO fact sheet of 2021, non-communicable diseases (NCDs), also known as chronic diseases, are responsible for the death of about 41 million people each year, which was about 71% of the total deaths recorded all over the world in 2021. As per the same source, every year, over 15 million people aged between 30-69 die due to NCDs across the world. Therefore, the demand for treatment procedures is increasing owing to the high burden of mortality due to NCDs. Thus, the market studied is expected to grow over the forecast period.
The rising adoption of MIS is expected to drive the overall growth of the market. MIS cause less post-operative pain. Besides, there are minimal cuts or stitches involved, the hospital stay is relatively shorter, and this technology is proving its efficiency in treatment while performing complex surgeries.
However, the high cost of the products and the requirement for skilled professionals are hampering the growth of the market.
Occlusion Devices Industry Segmentation
As per the scope of this report, occlusion devices are used to create occlusion in the vessels in order to stop the blood flow.
The occlusion devices market is segmented by product (occlusion removal devices (coil retrievers, stent retrievers, and other occlusion removal devices), embolization devices, and support devices), application (peripheral vascular disease, neurology, oncology, urology, and other applications), end user (hospitals, ambulatory surgical centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product | |||||
| |||||
Embolization Devices | |||||
Support Devices |
By Application | |
Peripheral Vascular Disease | |
Neurology | |
Oncology | |
Urology | |
Other Applications |
By End User | |
Hospitals | |
Ambulatory Surgical Centers | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Occlusion Devices Market Size Summary
The occlusion devices market is poised for significant growth, driven by the increasing acceptance of minimally invasive surgeries and advancements in medical technology. The market experienced a temporary setback due to the COVID-19 pandemic, which led to delays in surgical procedures and a decline in interventional radiology services. However, the market has rebounded as vaccination rates increased and COVID-19 cases declined. The rising prevalence of lifestyle-related and chronic diseases, such as non-communicable diseases, is fueling the demand for occlusion devices. These devices are becoming increasingly essential in treating conditions like brain aneurysms, which are influenced by factors such as hypertension and genetic predisposition. The geriatric population's growth is expected to further increase the incidence of such conditions, thereby driving market expansion.
North America is anticipated to lead the occlusion devices market, supported by a robust healthcare infrastructure and a high adoption rate of minimally invasive surgeries. The region's market growth is further bolstered by the approval of new occlusion devices, such as Abbott Laboratories' Amplatzer Piccolo Occluder, which offers innovative treatment options for congenital heart conditions. The rising incidence of cardiovascular diseases and cancer in the United States is also contributing to the market's growth, as these conditions necessitate interventional procedures. The market is characterized by a few major players, including Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC, who are continuously innovating and expanding their product offerings to meet the growing demand.
Occlusion Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Adoption of Minimally Invasive Surgeries
-
1.2.2 Increasing Geriatric Population and Rising Burden of Chronic Diseases
-
1.2.3 Technological Advancements
-
-
1.3 Market Restraints
-
1.3.1 High Cost of the Products
-
1.3.2 Requirement of Skilled Professionals
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Occlusion Removal Devices
-
2.1.1.1 Coil Retrievers
-
2.1.1.2 Stent Retrievers
-
2.1.1.3 Other Occlusion Removal Devices
-
-
2.1.2 Embolization Devices
-
2.1.3 Support Devices
-
-
2.2 By Application
-
2.2.1 Peripheral Vascular Disease
-
2.2.2 Neurology
-
2.2.3 Oncology
-
2.2.4 Urology
-
2.2.5 Other Applications
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
2.3.3 Other End Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Occlusion Devices Market Size FAQs
What is the current Occlusion Devices Market size?
The Occlusion Devices Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in Occlusion Devices Market?
Abbott Laboratories, Boston Scientific Corporation, BTG International Ltd, Edwards Lifesciences Corporation and Medtronic plc are the major companies operating in the Occlusion Devices Market.